In other countries
The same active substances on other registers, the same brand first.
- CosmegenBrazil · Prodome Química e Farmacêutica LtdaSame brand
- CosmegenBrazil · Laboratórios Bagó do Brasil S/ASame brand
- CosmegenBrazil · Organon Farmacêutica Ltda.Same brand
- CosmegenItaly · Polvere per soluzione iniettabile · Recordati Rare Diseases SarlSame brand
- CosmegenNew Zealand · Inj 0.5 mg vialSame brand
- CosmegenUnited States · 0.5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · Recordati RareSame brand
- BaxterNew Zealand · Inj 0.5 mg for ECPSame substance
- K. U. DACTINOMYCIN FOR INJECTION 0.5 mg/vialSingapore · 0.5 mg/vial · injection, powder, for solution · Shoei Universal Corporation Pte LTDSame substance
- DactinomycinUnited States · 0.5MG/VIAL · injectable · HikmaSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Dactinomycin
- Strength
- 0.5 MG / VIAL
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 31 Dec 1963
- Registration
- DIN 00213071
- Marketing authorisation holder
- Recordati Rare Diseases Canada INC
- ATC code
- L01DA01
- Supply
- PRESCRIPTION